BEGIN:VCALENDAR PRODID:-//Microsoft Corporation//Outlook 16.0 MIMEDIR//EN VERSION:2.0 METHOD:PUBLISH X-MS-OLK-FORCEINSPECTOROPEN:TRUE BEGIN:VTIMEZONE TZID:Eastern Standard Time BEGIN:STANDARD DTSTART:16011104T020000 RRULE:FREQ=YEARLY;BYDAY=1SU;BYMONTH=11 TZOFFSETFROM:-0400 TZOFFSETTO:-0500 END:STANDARD BEGIN:DAYLIGHT DTSTART:16010311T020000 RRULE:FREQ=YEARLY;BYDAY=2SU;BYMONTH=3 TZOFFSETFROM:-0500 TZOFFSETTO:-0400 END:DAYLIGHT END:VTIMEZONE BEGIN:VEVENT CLASS:PUBLIC CREATED:20210323T131008Z DESCRIPTION:American Thoracic Society- ATS 2021\nInternational Participants Center\n \nEvent Name: What Do We Know About the Implementation of COPD G uidelines of Low- and Middle-Income Countries?\nDate: 10 - 11 a.m. EDT\, S unday\, May 16\, 2021\n\nRegister for ATS 2021 and join us for these progr ams at the International Participants Center. \n \nCOPD is the most common cause of chronic re spiratory disease worldwide. Indeed\, its prevalence currently exceeds 250 million and more than 3 million people die from this disease die each yea r. Evidence-based strategies for the diagnosis\, management and prevention of COPD exist\; however\, little has been done to tailor these recommenda tions to the realities of many low- and middle-income country settings. Th is session aims to provide a brief discussion about existing challenges\, solutions and key stakeholders to combat COPD in the poorest regions in th e world.\n \nIntroduction: Epidemiology of COPD worldwide (5 minutes)\nCha ir: William Checkley\, MD\, PhD \n \nTopic 1: Gaps in the availability of COPD guidelines in low-resource settings: What do we know? (10 minutes)\nS peaker: Job Van Boven\, PharmD\, PhD (Groningen University – Netherlands ) \n \nTopic 2: Practical recommendations how to address current challenge s: What can we do to improve COPD care? (10 minutes)\nSpeaker: John Hurst\ , MBBS\, PhD (University College London – UK)\n \nTopic 3: Role of multi national organizations in fighting COPD worldwide: What is achievable in 2 0 years? (10 minutes)\nSpeaker: Sarah Rylance\, MBBS\, PhD (WHO – Switze rland)\n \nQ&A (10 minutes)\n1. How are COPD guidelines perceived and used in LMICs\, and what guidelines are in real-world use?\n2. What are the ba rriers and facilitators to implementation of universal\, evidence-based\, guideline-driven cost-effective interventions for COPD in LMICs?\n3. How c an the respiratory community lead changes resulting in the wider introduct ion of evidence-based care for COPD in LMICs?\n DTEND;TZID="Eastern Standard Time":20210516T110000 DTSTAMP:20210323T131008Z DTSTART;TZID="Eastern Standard Time":20210516T100000 LAST-MODIFIED:20210323T131008Z PRIORITY:5 SEQUENCE:0 SUMMARY;LANGUAGE=en-us:What Do We Know About the Implementation of COPD Gui delines of Low- and Middle-Income Countries? TRANSP:OPAQUE UID:040000008200E00074C5B7101A82E0080000000000DF73E2C21FD701000000000000000 010000000C42931A965D4DF45A5318B5E208762A8 X-ALT-DESC;FMTTYPE=text/html:

Am erican Thoracic Society- ATS 2021

International Participants Center

 \;

Event Name: What Do We Know About the Implementation of COPD Guidelines of Low- and Middle-Incom e Countries?

Date: 10 - 11 a.m. EDT\, Sunday\, May 16\, 2021


Register for ATS 2021 and join us for these programs at the International Participants Center.

 \;

< p class=MsoNormal style='margin-bottom:0in'>COPD is the most common cause of chronic respiratory disease worldwide. Indeed\, its prevalence currentl y exceeds 250 million and more than 3 million people die from this disease die each year. Evidence-based strategies for the diagnosis\, management a nd prevention of COPD exist\; however\, little has been done to tailor the se recommendations to the realities of many low- and middle-income country settings. This session aims to provide a brief discussion about existing challenges\, solutions and key stakeholders to combat COPD in the poorest regions in the world.

 \;

Introduction: Epidemiology of COPD worldwide (5 minutes)

Chair: William Checkley\, MD\, PhD

 \;

Topic 1: Gaps in the availability of COPD guidelines in low-resource settings: What do we know? (10 minutes)

Speaker: Job Van Boven\, PharmD\, PhD (Groningen Universit y –\; Netherlands)

 \;

Topic 2: Practical recommendations how to address current challe nges: What can we do to improve COPD care? (10 minutes)

Speaker: John Hurst\, MBBS\, PhD (University College London –\; UK)

 \;

Topic 3: Role of multinational organizations in f ighting COPD worldwide: What is achievable in 20 years? (10 minutes)< /o:p>

Speaker: Sarah Rylan ce\, MBBS\, PhD (WHO –\; Switzerland)

 \;

Q&\;A (10 minutes)

1. How are COPD guidelines perceived an d used in LMICs\, and what guidelines are in real-world use?

2. What are the barriers and facilitators to implementation of universal\, evidence-based\, guideline- driven cost-effective interventions for COPD in LMICs?

3. How can the respiratory communi ty lead changes resulting in the wider introduction of evidence-based care for COPD in LMICs?

X-MICROSOFT-CDO-BUSYSTATUS:BUSY X-MICROSOFT-CDO-IMPORTANCE:1 X-MICROSOFT-DISALLOW-COUNTER:FALSE X-MS-OLK-AUTOFILLLOCATION:TRUE X-MS-OLK-CONFTYPE:0 BEGIN:VALARM TRIGGER:-PT15M ACTION:DISPLAY DESCRIPTION:Reminder END:VALARM END:VEVENT END:VCALENDAR